National Health Investors - NHI Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings or view top-rated stocks.

3 analysts have issued 12-month target prices for National Health Investors' shares. Their NHI share price forecasts range from $51.00 to $64.00. On average, they predict the company's stock price to reach $59.00 in the next twelve months. This suggests that the stock has a possible downside of 0.4%.
View analysts price targets for NHI or view top-rated stocks among Wall Street analysts.

National Health Investors' stock was trading at $57.47 at the beginning of the year. Since then, NHI shares have increased by 3.1% and is now trading at $59.24.
View the best growth stocks for 2022 here.

National Health Investors saw a increase in short interest in August. As of August 31st, there was short interest totaling 1,160,000 shares, an increase of 10.5% from the August 15th total of 1,050,000 shares. Based on an average daily trading volume, of 274,800 shares, the short-interest ratio is currently 4.2 days. Currently, 2.7% of the shares of the stock are short sold.
View National Health Investors' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our NHI earnings forecast.

National Health Investors, Inc. (NYSE:NHI) issued its earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.63 by $0.45. The real estate investment trust had revenue of $71.33 million for the quarter, compared to analysts' expectations of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 4.52% and a net margin of 24.52%. The business's revenue for the quarter was down 11.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.24 earnings per share.

National Health Investors announced a quarterly dividend on Monday, August 8th. Shareholders of record on Friday, September 30th will be given a dividend of $0.90 per share on Friday, November 4th. This represents a $3.60 annualized dividend and a dividend yield of 6.08%. The ex-dividend date of this dividend is Thursday, September 29th.
Read our dividend analysis for NHI.

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 5.93%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 20 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 246.58%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 77.75% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

National Health Investors issued an update on its FY 2022 earnings guidance on Tuesday, September, 6th. The company provided earnings per share (EPS) guidance of $3.86-$3.92 for the period. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

National Health Investors' stock is owned by a number of institutional and retail investors. Top institutional shareholders include State Street Corp (4.91%), Macquarie Group Ltd. (3.05%), Northern Trust Corp (1.41%), Sumitomo Mitsui Trust Holdings Inc. (1.35%), Rush Island Management LP (1.01%) and Legal & General Group Plc (0.64%). Insiders that own company stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends.

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NHI stock can currently be purchased for approximately $59.24.

National Health Investors (NYSE:NHI) has a market capitalization of $2.65 billion and generates $298.71 million in revenue each year. The real estate investment trust earns $111.80 million in net income (profit) each year or $1.46 on an earnings per share basis.

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The official website for the company is www.nhireit.com. The real estate investment trust can be reached via phone at (615) 890-9100, via email at investorrelations@nhireit.com, or via fax at 615-225-3030.